LAS VEGAS - nvtip -- The award-winning company and leader in telehealth, MedWand™ Solutions, Inc, has announced the debut of its latest creation in MedWand™ Kits: the Mobile Screen, Quarantine, Monitor (SQM) DOC. Equipped for the war against the spread of the coronavirus, Medwand's Mobile SQM unit includes a hand-held, cutting-edge, telehealth MedWand™ device that houses ten diagnostic tools, a UV sanitation device, a two-in-one touch screen tablet, wooden tongue depressors, and more, to provide a solution to help monitor and detect patients who are believed to, or already have, contracted the Covid-19 virus.

"MedWand has the ability to help save many lives and is easy to use. MedWand™ can help with triage, monitoring people in quarantine, and examining people for other conditions without bringing them into a potentially contaminated area," shared Samir Qamar, M.D., Co-Founder and CEO of MedWand™ Solutions. "It has web-based software with military-grade encryption - we have the right tool at the right time, and we can deploy it fast."

More on nvtip.com

• Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
• HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
• Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
• OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
• P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport

The MedWand™ device allows clinicians to conduct remote office visits, through the real-time collection of multiple vital sign readings and key patient assessments. It can listen to your heart and lungs, measure respiratory rates and blood oxygen levels, take your temperature, scan your skin and even look at your tonsils. All of this information gets sent in real time to your doctor who watches, listens, and interacts through a secure video portal on their computer.

The latest Medwand™ device kit, SQM DOC, offers monitoring with zero risk of infection, while tracking and monitoring trends in real-time. Each SQM DOC contains a sanitation device that uses UV technology, allowing a single MedWand™ to be used by multiple patients. The kit also includes anti-microbial wipes, sixty disposable wooden tongue depressors that can be inserted into the MedWand™ so the high-resolution camera can capture a clear photo of the back of the throat, the MedWand™ device, and a touchscreen tablet pre-configured and loaded with Medwand™ application to allow a real-time doctor visit. The mobile doc unit is packaged in a ruggedized protective carrying case.

More on nvtip.com

• DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
• French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
• LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
• Back-to-College Organization Starts at Home with PODS® Las Vegas
• Don Barnhart Brings His NFTG Tour Home as Delirious Celebrates One Year at Silver Sevens

"MedWand™ has specific diagnostic instruments to remotely examine coronavirus patients, so we filed for an emergency use authorization with the FDA. We hope this will get approved quickly and should allow us to get these devices into the right hands, right away," added Dr. Qamar. "This is the future of healthcare. MedWand™ offers a solution to help stop the spread of contagious diseases."

MedWand™ is an award-winning device created by physicians and medical device engineers. The handheld product includes a stethoscope, otoscope, dermatoscope, throat illuminator with camera, IR thermometer, ECG, and pulse oximeter (SpO2, heart rate, respiratory rate). In addition to the Mobile SQM DOC, Medwand™ solutions also offers a Home DOC, Office DOC, and Mobile DOC. For more information on MedWand and the creators behind the device visit www.medwand.com. Pending clearance by the FDA. Not available for sale in all countries.

Follow us on Twitter

Like us on Facebook

Follow us on Instagram